Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab170548 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Brentuximab (anti-TNFRSF8)
- Antibody type
- Recombinant
- Description
- Brentuximab (anti-TNFRSF8) is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Brentuximab (anti-TNFRSF8) (Ab170548) - ELISA Immobilized huCD30-his 2 μg/mL can bind Brentuximab (anti-TNFRSF8) (Ab170548) with the EC₅₀ of 6.00 ng/mL.
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Brentuximab (anti-TNFRSF8) (Ab170548) - Flow Cytometry Flow Cytometry analysis of Jurkat cells labelling TNFRSF8 (red) with Brentuximab (anti-TNFRSF8) (Ab170548). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
